跳至主要内容
临床试验/CTRI/2024/06/068808
CTRI/2024/06/068808尚未招募不适用

A study on efficacy of fractional CO2 LASER with topical Latanoprost vs fractional CO2 LASER with topical Tofacitinib in stable vitiligo - An interventional study

Bommaka Sruthi1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2024年6月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
58
试验地点
1
主要终点
Repigmentation will be assessed using dermoscopy and photographic assessment using MIISP score and GPA score

研究概览

简要总结

This study is to determine the efficacy of fractional CO 2 LASER with topical Latanoprost versus topical Tofacitinib in treatment of stable vitiligo patients, Fractional CO 2 LASER, Fractional CO2 LASER will be done every two weekly once at that time either of the two topical agents according to randomization will be given and patient will be advised to use the same topical agent till completion of 8 weeks. Topical Tofacitinib 2% and Topical Latanoptost are Melanocyte stimulating agents and hence are tried in treatment of vitiligo, as of now no study has compared these groups. Thus making this study first of its kind.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
6.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • All patients above 6 years of age.

排除标准

  • Patients with keloidal tendency Pregnant or lactating women Patients with vitiligo associated syndromes Patients who are not willing to participate in study.

结局指标

主要结局

Repigmentation will be assessed using dermoscopy and photographic assessment using MIISP score and GPA score

时间窗: Baseline, 4weeks, 8weeks.

次要结局

  • Adverse effects of fractional CO2 LASER, Tofacitinib, Latanoprost.(Before each sitting -every 2 weeks and)

研究者

发起方
Bommaka Sruthi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Bommaka Sruthi

Sri Devaraj Urs Academy of Higher Education and Research

研究点 (1)

Loading locations...

相似试验